openPR Logo
Press release

Osteoarthritis Market Size, Share, Growth, Analysis By Type, By Treatment, By Diagnosis, By Operative Areas and Key Player Profiles up Forecast 2021 to 2031

10-04-2021 09:14 AM CET | Health & Medicine

Press release from: Sheer Analytics and Insights Pvt. Ltd.

Osteoarthritis Market Size, Share, Growth, Analysis By Type,

According to a global Osteoarthritis Market report, published by Sheer Analytics and Insights, The Global Osteoarthritis Market was valued at $250 billion in 2020. Growing at a high CAGR of 12.7% between 2021 and 2031, it is estimated to reach $930 billion by 2031.

Asia-Pacific region is anticipated to be the most lucrative destination for osteoarthritis surgical treatment in terms of market share. The revenue generation from this region is expected to increase at a CAGR of 17.6% over the forecast period. Europe and North America are other attractive regions in terms of market share. However, the revenue in these regions is expected to increase at competitive CAGRs of 9.6% and 10.7% in the global osteoarthritis market. Revenue generation of osteoarthritis treatment in the Latin America, Middle East, and Africa (LAMEA) region is estimated to be valued at $26.69 Bn by the end of 2021. It is expected to increase at a CAGR of 16.1% over the forecast period. The report covers a detailed analysis of the osteoarthritis treatment arena on a permanent and temporary basis.

Click Free Request Sample Here: https://www.sheeranalyticsandinsights.com/request-sample/osteoarthritis-market-21

Obesity is one of the most common reasons cause osteoarthritis in most people worldwide. The other reasons for osteoarthritis are the increasing geriatric population, busy lifestyle, injury due to high physical stress in sports, fieldwork, and weight training. According to OECD, U.S. has an obese population of more than 36% in 2021 and is ranked 12th in the health index. While globally, around 12.6% population is obese, and around 32% of them are suffering from osteoarthritis problems. Osteoarthritis is primarily found in women more than men. Medical tourism has encouraged the treatment of osteoarthritis. As per Sheer Analytics, it has been found that the average treatment cost for any replacement is six times higher in developed nations. It is estimated that in developed countries, osteoarthritis cost is between USD 20000 to 50000, while in developing regions, its cost is around USD 3000-6000. Therefore, countries like China and India have shown a significant surge in treatment of such types of patients via medical tourism. The increase in osteoarthritis patients also encouraged the healthcare industry to do significant research and development and increase the pace of osteoarthritis research and developments.

This growth is restricted by the number of hospitals and specialistic clinics operating in developing regions. While developed regions have all advanced facilities, the number of orthopedic surgeons in these countries is too restricted. Due to lack of confidence and monetary constraints, around 80% of the people suffering from osteoarthritis are not going for replacement surgeries. The other factor limiting the treatment of Osteoarthritis is the limited availability of medicines specifically for osteoarthritis treatment. Due to the higher cost of these medicines, patients take these medicines for a temporary period and leave medicines due to their higher cost, especially in developing regions.

According to our study, key players in the Global Osteoarthritis Market include Abbott Laboratories, Anika Therapeutics, Inc., Bayer AG, Bioventus LLC, Eli Lilly and Company, Ferring Pharmaceuticals, Fidia Farmaceutici SPA, Flexion Therapeutics, GlaxoSmithKline PLC (GSK), Horizon Therapeutics Plc., Johnson & Johnson, Novartis International AG, Novo Nordisk A/S, Pfizer Inc., Pharmed Ltd, Sanofi S.A., and Zimmer Biomet Holding Inc

Click full report with ToC: https://www.sheeranalyticsandinsights.com/market-report-research/osteoarthritis-market-21

The Global Osteoarthritis Market Has Been Segmented into:

Global Osteoarthritis Market: By Type

Hip
Spinal
Knee
Wrist

Global Osteoarthritis Market: By Treatment

Medication and ointments
Physiotherapy
Surgery

Global Osteoarthritis Market: By Diagnosis

Imaging
Joint Fluid Analysis

Global Osteoarthritis Market: By Operative Areas

Hospitals
Clinics

Global Osteoarthritis Market: By Region

North America
Europe
Asia Pacific
LAMEA (Latin America, Middle East, and Africa)

Click Free PDF Sample Request: https://www.sheeranalyticsandinsights.com/request-sample/osteoarthritis-market-21

About Us

Sheer Analytics and Insights Private Limited is market research, consulting, and IT services company. We as a company believe in providing point to point data and its analysis with the combination of our human and automation integration. Sheer Analytics and Insights cover majorly eight industry verticals, including chemicals, life science, communications, electronics, materials, consumer goods, defense, and BFSI sector.

Sheer Analytics believes in quality work and ensures that the product delivered to the client is meaningful for them. We publish reports based on our advanced analytics reports, which are generated with the help of our in-house databases, external databases, and artificial intelligence integration processes. We stand out from other market research companies in terms of integrating facts with meaningful insights for forecasting.

Apart from publishing syndicated reports (mostly client reports), we are dealing with projects primarily based on “Go to Market Strategy, Data Mining and Extraction,” meaning full data analysis based on big data and many other database services and content related services.

Our products include quick turnaround datasets, TAM/PAM Analysis to full-fledged deep dive research on top trending markets.

Contact:

Abhigyan Sengupta

Sheer Analytics and Insights

Email: query@sheeranalyticsandinsights.com

+1-414-240-5010

Website: https://www.sheeranalyticsandinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osteoarthritis Market Size, Share, Growth, Analysis By Type, By Treatment, By Diagnosis, By Operative Areas and Key Player Profiles up Forecast 2021 to 2031 here

News-ID: 2414699 • Views: 281

More Releases from Sheer Analytics and Insights Pvt. Ltd.

Global Bronchial Thermoplasty market expected to reach US$ 99.68 Bn by 2026: Mar …
Sheer Analytics and Insights Pvt. Ltd. have published a report on the global Bronchial Thermoplasty market titled Global Bronchial Thermoplasty Market (By Age Group: 18-30 years, 30-50 years, and Greater than 50 years. By Regions: North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2018 – 2026. The market is estimated to reach US$ 99.68 Bn by the
Global cell-based assay market expected to grow at 9% CAGR between 2017 and 2025 …
Sheer Analytics and Insights Pvt. Ltd. has published a report on the global Cell-Based Assay market titled Global Cell-Based Assay Market (By Product Type: Assay kits, Instruments, Reagents, Software and Services. By Application- Toxicology, ADME Studies and Drugs Discovery, By End-user- Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations and By Regions) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025. The market is
Global bioinformatics market expected to grow at 13.20% CAGR between 2018 and 20 …
Sheer Analytics and Insights Pvt. Ltd. has published a report on the global bioinformatics market titled Global Bioinformatics Market (By Products and Services: - Knowledge Management Tools, Bioinformatic Services and Bioinformatics Platform. By Application- Chemoinformatic, Genomics, Proteomics, Transcriptomics, Metabolomics and Others, By End-user- Pharmaceuticals, Education, Forensic, Environment and Others and By Regions) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025. The market is estimated to
Global 3D Cell Culture Market Revenue will reach US$ 3,134.25 Mn by 2025 - Indus …
Sheer Analytics and Insights Pvt. Ltd. has published a report on the global 3D cell culture market titled Global 3D Cell Culture Market (By Technology: Scaffold-Based, Scaffold-Free and 3D Bioreactor. By Application- Tissue Engineering, Organ-on-Chips, Drugs Discovery and Testing, Cancer Research and Others, By End-user- Research Institutes, Hospitals, Pathology Laboratories and Others and By Regions) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025. The market

All 5 Releases


More Releases for Osteoarthritis

Osteoarthritis Treatment Market by Product (Drugs, Hyaluronic acid Injection) by …
Global Osteoarthritis Treatment Market was valued at USD XX Billion in the year 2017. Global Osteoarthritis Treatment Market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX Billion by the year 2023. Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE369 North America region holds the highest market share in 2017 and is considered as the fastest growing market in the forecasted period. At a
Osteoarthritis-Pipeline Review H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis-Pipeline Review, H2 2017, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint
Osteoarthritis Global Clinical Trials Review, H1, 2016
ReportsWeb.com published “Osteoarthritis” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. GET Sample Copy at http://www.reportsweb.com/inquiry&RW0001178647/sample Reason to Buy Original Content: - The UK and the EU will be at the forefront of moves to practically apply the principles of open banking in 2017, spurred on by regulatory demands. The
Osteoarthritis - Pipeline Review, H2 2017
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H2 2017, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older
Osteoarthritis - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H1 2017, provides an overview of the Osteoarthritis (Immunology) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries
Osteoarthritis Pharmaceutical and Healthcare Pipeline Review H2
Pune, India, 28th August 2017: WiseGuyReports announced addition of new report, titled “Osteoarthritis - Pipeline Review, H2 2017”. Summary Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries and obesity. Treatment includes surgery,